Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

NCT03209518 · clinicaltrials.gov ↗
COMPLETED
Status
312
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda